Cytotoxicity of Nubein6.8 peptide isolated from the snake venom of Naja nubiae on melanoma and ovarian carcinoma cell lines

Abstract

This study was conducted to examine the cytotoxic effects of Nubein6.8 isolated from the venom of the Egyptian Spitting Cobra Naja nubiae on melanoma (A375) and ovarian carcinoma cell lines and to reveal its mode of action. The size of Nubein6.8 (6801.8 Da) and its N-terminal sequence are similar to cytotoxins purified from the venom of other spitting cobras. Nubein6.8 showed a high significant cytotoxic effect on A375 cell line and moderate effect on A2780. A clonogenic assay showed that Nubein6.8 has a significant long-term potency on A375 cell survival when compared to A2780. The molecular intracellular signaling pathways of Nubein6.8 have been investigated using Western blotting analysis, flow cytometry, and microscale protein labeling. This data revealed that Nubein6.8 has DNA damaging effects and the ability to activate apoptosis in both tumor cell lines. Cellular uptake recordings revealed that the labeled-Nubein6.8 was intracellularly present in A375 cells while A2780 displayed resistance against it. SEM examination showed that Nubein6.8 was found to have high accessibility to malignant melanoma cells. The apoptotic effect of Nubein6.8 was confirmed by TEM examination that revealed many evident characteristics for Nubein6.8 apoptotic efficacy on A375 cell sections. Also, TEM reflected many resistant characteristics that faced Nubein6.8 acquisition through ovarian carcinoma cell sections. Accordingly, the snake venom peptide of Nubein6.8 is a promising template for developing potential cytotoxic agents targeting human melanoma and ovarian carcinoma.

Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review

“…During wound healing, a variety of cells such as inflammatory cells, fibroblasts, keratinocytes, endothelial cells, and growth factors as well as enzymes are involved (Velnar et al, 2009;Abdel-Ghani et al, 2019;Makvandi et al, 2019). The presence of other diseases such as DM impairs wound healing, demanding novel intervention to improve wound process by enhancing growth factor production, induction of angiogenesis, elevating collagen accumulation and macrophage function (Falanga, 2005;Campos et al, 2008).…”

Antimicrobial Peptides as New Combination Agents in Cancer Therapeutics: A Promising Protocol against HT-29 Tumoral Spheroids

“…Spheroids were obtained after seeding 5000 cells/well and were grown for three days. On the third day of spheroid growth, different concentrations of Doxo (20,50,75, and 100 μg/mL) and GA (10,20,40, and 60 μM) were added and the effects were monitored through transmission microscopy at 24 and 48 h. The scale bar is 200 μm and is the same for all images.…”

“…After 3 days, the treatments with the Doxo and GA, either separately or in combination, were applied. Doxo alone was added in four concentrations (20,50,75, and 100 µg/mL), while GA alone was also added in four concentrations (10,20,40, and 60 µM). For the combined treatment, we two different GA concentrations were used (10 and 20 µM), each in combination with the other 4 Doxo concentrations.…”

“…Compared to the healthy cell membranes, cancer cell membranes are negatively charged, facilitating the attachment of the peptide to the membrane, followed by its disruption through different mechanisms. Moreover, AMPs have a reduced toxicity to rapid proliferating healthy cells [7][8][9][10]. Depending on the peptide structure and concentration, different AMP action mechanisms have been described, such as the formation of membrane detergent-like "carpets" or of discrete membrane pores that dissipate the ion gradients [11][12][13].…”

Proteomic Investigations of Two Pakistani Naja Snake Venoms Species Unravel the Venom Complexity, Posttranslational Modifications, and Presence of Extracellular Vesicles

“…For example, a recent study reported Mambaquaretin-1 (peptide from green mamba venom), as a promising candidate for the treatment of polycystic kidney disease [ 39 ]. Another study described Nubein6.8, a peptide from the venom of N. nubiae , as a promising template for the treatment of human melanoma and ovarian cancer [ 40 ].…”